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Introduction 
Rhabdomyosarcoma is a malignant tumour of skeletal muscle,accounting for circa 45% of all head and 
neck sarcomas, with the orbit and nasopharynx being the sites most commonly affected [1]. The alveolar 
subtype of rhabdomyosarcoma, encompassing 30% of children with rhabdomyosarcoma [2], has one of 
the worst prognoses, with a five year survival of 29%, along with one of the highest rates of metastasis [2] 
and an incidence of 1 case per million children and adolescents [3]. 
We present a case of an 18-year-old male with left maxillary alveolar rhabdomyosarcoma and diffuse bone 
metastases. Clinically, his eye was abnormally protruded (proptosed) with swollen conjunctiva (chemosis) 
leading to lower lid retraction and conjunctival abrasions. There was also a significant burden of visible 
bulky circumferential periorbital disease (Figure 1A).  
While in  the specialist palliative care inpatient unit, the patient developed worsening visual acuity and 
mild photophobia, finding his eye’s autonomic response to light unpleasant. Initially, this was covered 
with a non-woven, non-sterile swab, adhered with 3M Durapore tape, which both protected the eye from 
the environment, and removed it from the patient’s own view.. A commercially available plastic eye 
covering was  insufficiently concave to accommodate the patient’s eye and was not satisfactory to the 
patient.  
The clinical team requested the Rapid Innovation Unit (RIU) at the University of Limerick to create a 
bespoke eye cover.. The group had previous experience creating custom solutions for challenging clinical 
cases [4]. The brief, covering patient and clinical requirements, was that the eye cover be; plain black, 
discrete, light occluding, easily applied and removed, accommodate further potential  protrusion of the 
eye, retain moisture to minimise drying of the corneal surface,  be comfortable,  necessitate minimal 
handling of the cover by the patient and carers, to reduce infection risk (in particular COVID-19).  
 
Figure 1: (A) Left maxillary alveolar rhabdomyosarcoma with proptosis. (B) 3D scan data of face. (C) 3D render of 





A non-contact 3D scanner (iSense, 3D systems, Rock Hill, South Carolina, United States) was used to 
capture the relevant surface topography of the patients face in a single five minute visit. The data were 
post processed with the included iSense scanner software, cropped to include only the orbital area 
immediately surrounding the eye, and exported in OBJ file format. The file was imported into SolidWorks 
CAD software (Dassault systems, France) and used as the master surface onto which an eye cover was 
designed as a bespoke fit (Figure 1B).  
On outline was created that extended beyond the borders of any oedema associated with the 
rhabdomyosarcoma. Using a series of guidelines and surfaces, a structure was designed with a 5mm 
clearance between the highest point of the pupil and the inside of the cover. The structure was thickened 
to 1.2mm for strength, and a wider rim modelled where the cover contacts the skin. Two attachment 
loops were added to the model for use with an adjustable elasticated headband (Figure 1C). As per the 
clinical brief, the cover was designed with a complete seal at the skin to reduce moisture loss. 
The cover was exported as a .STL file and printed on a Figure 4 Standalone 3D printer (3D systems, Rock 
Hill, South Carolina, United States) using the Pro Black-10 material. The material is certified by the 
manufacturer as skin contacting under ISO-10993. The total print time was 1 hour 15 minutes, plus an 
additional 90 minutes of post curing to fully solidify the cover.  
A 1:1 model of the patients orbital area was created separately using a Connex 500 3D printer (Stratasys, 
Rehovot, Israel) to verify the fit of the cover prior to testing with the patient which minimised the need 
for multiple fitments and significantly reduced patient contact. A wide, elasticated, adjustable headband 
was re-purposed from an LED head torch to fit the cover and maintain it in place over the eye. 
Results 
The cover met all the requirements outlined by the patient and clinical team. The 3D scan was performed 
on a Wednesday morning, with the finished cover assessed and accepted by the patient and clinical team 
on Friday afternoon (Figure 1D). The 3D printer material cost was €5.37. The patient’s clinical condition 
deteriorated quickly in the subsequent weeks. The eye cover was used intermittently at first over a short 
number of days. In the latter stage of his illness it was removed. 
Conclusions  
The use of 3D printing across the field of medicine has increased considerably in recent years, primarily 
for orthopaedic applications, surgical guides, anatomical models and pre-operative planning [5]. Its use to 
create end-user bespoke solutions outside of these clinical applications is not common. To the best of our 
knowledge, this is the first reported case of 3D printing being used to create a bespoke solution for a 
patient with Rhabdomyosarcoma. 
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